These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2749158)

  • 1. The interference of an autoimmune mechanism in the pathogeny of chronic active liver diseases.
    Banciu T; Arcan P; Văcariu V; Tudose N
    Med Interne; 1989; 27(1):47-52. PubMed ID: 2749158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Humoral and cell-mediated immunity in the comparison of autologous hepatocytes in chronic active viral and autoimmune hepatitis].
    Mazzetti M; Zunarelli P; Cicognani G; Tisselli N; Pignatelli M; Baldini R; Pirillo L; Stefanini GF
    G Clin Med; 1982 Oct; 63(10):678-87. PubMed ID: 6985033
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.
    Eggink HF; Houthoff HJ; Huitema S; Gips CH; Poppema S
    Clin Exp Immunol; 1982 Oct; 50(1):17-24. PubMed ID: 6983407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody dependent cytotoxicity in chronic active liver disease.
    Banciu T; Arcan P
    Gastroenterol Jpn; 1988 Dec; 23(6):695-7. PubMed ID: 3220246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative in vitro studies of cell-mediated immunity in chronic liver diseases].
    Königstedt B; Zipprich R; Nilius R
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(2):113-21. PubMed ID: 3487441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the immune response play a role in the pathogenesis of chronic liver disease?
    Mondelli MU; Manns M; Ferrari C
    Arch Pathol Lab Med; 1988 May; 112(5):489-97. PubMed ID: 3282484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunomorphological studies of chronic hepatitis and liver cirrhosis].
    Tsoneva M; Ilieva P; Kuvandzhiev G
    Eksp Med Morfol; 1978; 17(1):50-4. PubMed ID: 639749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence and significance of IgG liver membrane autoantibodies (LMA) in chronic liver diseases of different aetiology.
    Meliconi R; Stancari MV; Garagnani M; Baraldini M; Stefanini GF; Miglio F; Gasbarrini G
    Clin Exp Immunol; 1983 Mar; 51(3):565-71. PubMed ID: 6342885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membranous expression of Lewis Y antigen in clustered hepatocytes in chronic viral, autoimmune, and alcoholic liver diseases but not in biliary diseases.
    Sasaki M; Kono N; Nakanuma Y
    Mod Pathol; 1994 Apr; 7(3):339-46. PubMed ID: 8058706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influencing immune perturbations by prolonged corticotherapy in the chronic active liver disease.
    Banciu T; Arcan P; Stroe A
    Med Interne; 1985; 23(3):177-83. PubMed ID: 4048798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in humoral and cellular immunologic changes in relation to the evolutive stage of chronic active liver disease.
    Banciu T; Argan P; Suşan L; Ocică I; Perţa D
    Med Interne; 1987; 25(1):25-30. PubMed ID: 3495858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spontaneous and interferon-induced activity of natural killer cells in patients with liver cirrhosis and chronic active hepatitis].
    Müller C; Zielinski CC
    Acta Med Austriaca; 1987; 14(5):115-8. PubMed ID: 3125713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological studies on chronic active hepatitis: possible involvement of macrophage-mediated cytotoxicity in its immunopathogenesis.
    Mizoguchi Y; Shiba T; Ohnishi F; Monna T; Yamamoto S; Morisawa S
    Hepatogastroenterology; 1981 Oct; 28(5):250-3. PubMed ID: 7047338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the etiology of chronic non-alcoholic liver disease in Naples and Copenhagen.
    Del Vecchio-Blanco C; Caporaso N; Tage-Jensen U; Di Sapio M; Schlichting P
    Scand J Gastroenterol; 1984 Nov; 19(8):1081-5. PubMed ID: 6398508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to liver membrane antigens in chronic active hepatitis (CAH). II. Specificity for autoimmune CAH.
    Frazer IH; Kronborg IJ; Mackay IR
    Clin Exp Immunol; 1983 Oct; 54(1):213-8. PubMed ID: 6616969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
    Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C
    Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular cytotoxicity against autologous hepatocytes in chronic hepatitis B--its relationship to the HBeAg/anti-HBe status.
    Poralla T; Hütteroth TH; Staritz M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Apr; 23(4):183-7. PubMed ID: 4060809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.